JPH0532680A - Optical resolution of optically active glutaric acid ester derivative - Google Patents
Optical resolution of optically active glutaric acid ester derivativeInfo
- Publication number
- JPH0532680A JPH0532680A JP3214534A JP21453491A JPH0532680A JP H0532680 A JPH0532680 A JP H0532680A JP 3214534 A JP3214534 A JP 3214534A JP 21453491 A JP21453491 A JP 21453491A JP H0532680 A JPH0532680 A JP H0532680A
- Authority
- JP
- Japan
- Prior art keywords
- glutaric acid
- acid ester
- salt
- optically active
- dehydroabietylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 glutaric acid ester Chemical class 0.000 title claims abstract description 19
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 title claims abstract 7
- 230000003287 optical effect Effects 0.000 title abstract description 12
- JVVXZOOGOGPDRZ-SLFFLAALSA-N [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine Chemical compound NC[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 JVVXZOOGOGPDRZ-SLFFLAALSA-N 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 239000011259 mixed solution Substances 0.000 claims abstract 4
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 14
- 125000006239 protecting group Chemical group 0.000 claims description 7
- 239000012452 mother liquor Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical group NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 229940117803 phenethylamine Drugs 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000013543 active substance Substances 0.000 description 6
- CTZDWHZODOCMCT-UHFFFAOYSA-N 3-[tert-butyl(dimethyl)silyl]oxy-5-methoxy-5-oxopentanoic acid Chemical compound COC(=O)CC(CC(O)=O)O[Si](C)(C)C(C)(C)C CTZDWHZODOCMCT-UHFFFAOYSA-N 0.000 description 5
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- ZQHYXNSQOIDNTL-UHFFFAOYSA-N 3-hydroxyglutaric acid Chemical compound OC(=O)CC(O)CC(O)=O ZQHYXNSQOIDNTL-UHFFFAOYSA-N 0.000 description 3
- KRHAHEQEKNJCSD-UHFFFAOYSA-N Dihydroasparagusic acid Natural products OC(=O)C(CS)CS KRHAHEQEKNJCSD-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- JYGAZEJXUVDYHI-UHFFFAOYSA-N dihydroartemisininic acid Natural products C1CC(C)=CC2C(C(C)C(O)=O)CCC(C)C21 JYGAZEJXUVDYHI-UHFFFAOYSA-N 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000011914 asymmetric synthesis Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- CTZDWHZODOCMCT-SECBINFHSA-N (3r)-3-[tert-butyl(dimethyl)silyl]oxy-5-methoxy-5-oxopentanoic acid Chemical compound COC(=O)C[C@@H](CC(O)=O)O[Si](C)(C)C(C)(C)C CTZDWHZODOCMCT-SECBINFHSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 229940123934 Reductase inhibitor Drugs 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical class C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、各種医薬品の原料とし
て有用な光学活性な3−ヒドロキシグルタル酸モノエス
テルの製造法を提供する。例えば、光学活性なHMG−
CoA還元酵素阻害剤を高収率で大規模に製造しうるた
めには、本発明が提供する光学活性な3−ヒドロキシグ
ルタル酸モノエステルは極めて重要である。FIELD OF THE INVENTION The present invention provides a method for producing an optically active 3-hydroxyglutaric acid monoester useful as a raw material for various pharmaceutical products. For example, optically active HMG-
The optically active 3-hydroxyglutarate monoester provided by the present invention is extremely important in order to be able to produce a CoA reductase inhibitor in high yield and on a large scale.
【0002】[0002]
【従来の技術】この種の光学活性体の製造法としては、
不斉合成法あるいは酵素によるエステル部分の加水分解
法などがよく知られている。しかしながら、従来用いら
れてきたこのような不斉合成法では、種々の特殊な試薬
を要したり、反応工程が繁雑であったりする。また、酵
素による方法では酵素の反応物の受容性や酵素反応の条
件設定に難しさがある。従って、これらの方法では光学
純度の高い活性体を容易に得られる例は余り知られてい
ない。2. Description of the Related Art As a method for producing an optically active substance of this type,
Asymmetric synthesis methods and enzymatic hydrolysis methods of ester moieties are well known. However, such asymmetric synthesis methods conventionally used require various special reagents or require complicated reaction steps. Further, the method using an enzyme has difficulty in setting the acceptability of the reaction product of the enzyme and the condition setting of the enzyme reaction. Therefore, there are few known examples of easily obtaining an active substance having high optical purity by these methods.
【0003】[0003]
【発明が解決しようとする課題】光学純度の高い化合物
を得ることは、医薬品を始めとする種々の化合物の合成
にとって、極めて重要な意味を有する。本発明は、ラセ
ミ体である3−ヒドロキシグルタル酸モノエステルを光
学分割することにより、光学活性体を効率良く取得する
方法である。Obtaining a compound having a high optical purity is extremely important for the synthesis of various compounds including pharmaceuticals. The present invention is a method for efficiently obtaining an optically active substance by optically resolving a racemic 3-hydroxyglutarate monoester.
【0004】[0004]
【課題を解決するための手段】本発明者らは、前述の事
情を鋭意研究した結果、中間体として有用な光学活性体
を得るための光学分割法を見出した。即ち、本発明は式
I:Means for Solving the Problems As a result of intensive studies on the above circumstances, the present inventors have found an optical resolution method for obtaining an optically active substance useful as an intermediate. That is, the invention provides formula I:
【化2】
(式中、R1はヒドロキシ保護基、R2は置換基を有して
いてもよい低級アルキル、*は不斉炭素原子をそれぞれ
表わす。)で示されるラセミ化合物の光学分割法を提供
するものである。[Chemical 2] (Wherein R 1 represents a hydroxy protecting group, R 2 represents a lower alkyl which may have a substituent, and * represents an asymmetric carbon atom, respectively). Is.
【0005】即ち、本製造法は下記方法により示され
る。ラセミ−3−tert−ブチルジメチルシリルオキシグ
ルタル酸モノメチルエステルに一方の光学活性な光学分
割剤を添加し、添加したのと同種の光学活性体を分離
し、更にその母液から他方の光学活性体を得る方法であ
る。更に詳しくは、ラセミ−3−tert−ブチルジメチル
シリルオキシグルタル酸モノメチルエステルに(+)−D
HAAを作用させることにより、R(-)−3−tert−ブ
チルジメチルシリルオキシグルタル酸モノメチルエステ
ルの(+)DHAA塩を得、該塩を塩分解することによ
り、R(-)−3−tert−ブチルジメチルシリルオキシグ
ルタル酸モノメチルエステル(I−1)を得る。更に
(+)−DHAA塩を分離した後、母液を処理することに
よりS(+)−3−tert−ブチルジメチルシリルオキシグ
ルタル酸モノメチルエステル(I−2)を得る方法であ
る。That is, this manufacturing method is shown by the following method. One optically active optical resolving agent was added to racemic-3-tert-butyldimethylsilyloxyglutaric acid monomethyl ester, the optically active substance of the same kind as that added was separated, and the other optically active substance was separated from the mother liquor. Is the way to get. More specifically, racemic-3-tert-butyldimethylsilyloxyglutaric acid monomethyl ester has (+)-D
By reacting with HAA, a (+) DHAA salt of R (-)-3-tert-butyldimethylsilyloxyglutarate monomethyl ester is obtained, and the salt is decomposed to give R (-)-3-tert. -Butyldimethylsilyloxyglutarate monomethyl ester (I-1) is obtained. Further
After separating the (+)-DHAA salt, the mother liquor is treated to obtain S (+)-3-tert-butyldimethylsilyloxyglutarate monomethyl ester (I-2).
【0006】本明細書中、ヒドロキシ保護基としては、
メチル、tert−ブチル、アリル、ベンジル、テトラヒド
ロピラニル、tert−ブチルジメチルシリルオキシ、tert
−ブチルジフェニルシリルオキシなどのエ−テル形成保
護基、アセチル、ベンゾイルなどのエステル形成保護
基、メチルスルホニル、p−トルエンスルホニル、フェ
ニルスルホニルなどのスルホン酸エステル形成保護基な
どが挙げられるが、本発明においては、エ−テル形成保
護基、特にtert−ブチルジメチルシリルオキシが好まし
い。In the present specification, the hydroxy protecting group includes
Methyl, tert-butyl, allyl, benzyl, tetrahydropyranyl, tert-butyldimethylsilyloxy, tert
Examples of the present invention include an ether-forming protective group such as -butyldiphenylsilyloxy, an ester-forming protective group such as acetyl and benzoyl, and a sulfonate ester-forming protective group such as methylsulfonyl, p-toluenesulfonyl and phenylsulfonyl. In, an ether-forming protecting group, especially tert-butyldimethylsilyloxy is preferred.
【0007】「置換基を有していてもよい低級アルキ
ル」とは、一般に直鎖状または分岐状の炭素原子1〜6
のアルキルを意味し、例えば、メチル、エチル、n−プ
ロピル、イソプロピル、n−ブチル、イソブチル、sec
−ブチル、tert−ブチル、n−ペンチル、イソペンチ
ル、ネオペンチル、tert−ペンチル、2−メチルブチ
ル、n−ヘキシルおよびイソヘキシルなどが挙げられ、
それぞれハロゲンまたはアミノ基で置換されていてもよ
い。The term "lower alkyl which may have a substituent (s)" generally means a linear or branched carbon atom of 1 to 6
Of alkyl, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec
-Butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, 2-methylbutyl, n-hexyl and isohexyl, and the like,
Each may be substituted with halogen or an amino group.
【0008】以下に実施例を示し、本発明を更に具体的
に説明するが、これらによって本発明の範囲は限定され
るものではない。実施例で用いられる略字は、以下に示
す意味を表わす。
Me:メチル
Et:エチル
TBDMS:tert−ブチルジメチルシリル
DHAA:デヒドロアビエチルアミンThe present invention will be described in more detail with reference to the following examples, which should not be construed as limiting the scope of the present invention. The abbreviations used in the examples have the following meanings. Me: Methyl Et: Ethyl TBDMS: tert-Butyldimethylsilyl DHAA: Dehydroabietylamine
【化3】 [Chemical 3]
【0009】参考例 (±)−3−tert−ブチルジメチルシリルオキシグルタ
ル酸モノメチルエステル
1 Reference Example (±) -3-tert-butyldimethylsilyloxygluta
Acid monomethyl ester 1
【化4】
粗製酸無水物30.0gを500mlのメタノ−ルに溶解
し、4時間還流する。減圧下で乾固し残分をトルエンに
溶解しシリカゲルカラムクロマトグラフィ−(トルエン
/酢酸エチル=4/1)にて付し、溶出物を減圧下で濃
縮し、残分をペンタンから氷冷下で結晶化させて目的化
合物27.2gを無色結晶として得られる(融点:54
〜55℃)
IR(Nujol):1700, 1730 cm-1
元素分析値(%)C12H24O5Siとして
計算値:C,52.12; H,8.75
実験値:C,51.90; H,8.721
HNMR(CDCl3, 200M)δ:0.07 (3H,s); 0.08 (3H,
s); 0.85 (9H,s); 2.60(4H,m); 3.68 (3H,s); 4.55 (1
H,m)[Chemical 4] 30.0 g of crude acid anhydride are dissolved in 500 ml of methanol and refluxed for 4 hours. It was evaporated to dryness under reduced pressure, the residue was dissolved in toluene and subjected to silica gel column chromatography (toluene / ethyl acetate = 4/1), the eluate was concentrated under reduced pressure, and the residue was removed from pentane under ice cooling. Crystallization gives 27.2 g of the desired compound as colorless crystals (melting point: 54
~55 ℃) IR (Nujol): 1700, 1730 cm -1 Elemental analysis (%) C 12 H calcd 24 O 5 Si: C, 52.12 ; H, 8.75 Found: C, 51.90; H, 8.72 1 HNMR (CDCl 3 , 200M) δ: 0.07 (3H, s); 0.08 (3H,
s); 0.85 (9H, s); 2.60 (4H, m); 3.68 (3H, s); 4.55 (1
H, m)
【0010】実施例1 R−(-)−3−tert−ブチルジメチルシリルオキシグル
タル酸モノメチルエステ
ル (I−1) Example 1 R-(-)-3-tert-butyldimethylsilyloxyglucurone
Tal acid monomethyl ester le (I-1)
【化5】
(1)R−(−)−3−tert−ブチルジメチルシリルオ
キシグルタル酸モノメチルエステルの(+)DHAA塩
2
(+)DHAA10.0g(36mmol)を50mlのメタ
ノ−ルに溶解し、そこへラセミの(±)−3−tert−ブ
チルジメチルシリルオキシグルタル酸モノメチルエステ
ル110.0g(35mmol)を加え、減圧下乾固する。
残分を100mlのペンタンに溶解し、種を植えて氷冷下
一晩静置する。析出した結晶を濾取して融点129〜1
30℃のR−(−)−3−tert−ブチルジメチルシリル
オキシグルタル酸モノメチルエステルの(+)DHAA
塩28.41gを得る。
[α]D+9.0°(C=2.0、 25.0℃、 MeOH)1
HNMR(200M,CDCl3)δ:0.04 (3H,s); 0.06
(3H,s); 0.84 (9H,s); 0.97(3H,s); 1.21 (6H,d,J=7H
z);1.22 (3H,s); 1.30〜1.85 (8H,m); 2.20〜2.95 (11
H,m); 3.64 (3H,s); 4.48 (1H,m); 6.68〜7.30 (3H,m)
元素分析値(%)C32H55NO5Siとして
計算値:C,68.40; H,9.87; N,2.49
実験値:C,68.18; H,9.74; N,2.57[Chemical 5] (1) R-(-)-3-tert-butyldimethylsilylio
(+) DHAA salt of monomethyl xyglutaric acid ester
10.0 g (36 mmol) of 2 (+) DHAA was dissolved in 50 ml of methanol, and 10.0 g (35 mmol) of racemic (±) -3-tert-butyldimethylsilyloxyglutaric acid monomethyl ester 1 was added thereto. Dry to dryness under reduced pressure.
The residue is dissolved in 100 ml of pentane, seeds are planted, and the mixture is allowed to stand under ice cooling overnight. The precipitated crystals are collected by filtration and have a melting point of 129 to 1
(+) DHAA of R-(−)-3-tert-butyldimethylsilyloxyglutarate monomethyl ester at 30 ° C.
8.41 g of salt 2 are obtained. [Α] D + 9.0 ° (C = 2.0, 25.0 ° C., MeOH) 1 HNMR (200M, CDCl 3 ) δ: 0.04 (3H, s); 0.06
(3H, s); 0.84 (9H, s); 0.97 (3H, s); 1.21 (6H, d, J = 7H
z); 1.22 (3H, s); 1.30 ~ 1.85 (8H, m); 2.20 ~ 2.95 (11
H, m); 3.64 (3H, s); 4.48 (1H, m); 6.68 ~ 7.30 (3H, m) Elemental analysis value (%) Calculated as C 32 H 55 NO 5 Si: C, 68.40; H, 9.87; N, 2.49 Experimental value: C, 68.18; H, 9.74; N, 2.57
【0011】(2)(I−1)の合成
得られた(+)DHAA塩28.41gを100mlのエ
−テル中に懸濁し、そこへ4N-HCl−酢酸エチル溶液1
0mlを加えて撹拌する。更に、ペンタン100mlを加え
て、撹拌した後析出物を濾去し、濾液を減圧下で濃縮す
る。残分をトルエンに溶解して、シリカゲルカラムクロ
マトグラフィ−(トルエン/酢酸エチル=2/1)に付
して光学純度96%ee以上の油状物として目的化合物
(I−1)4.10gを得る。
[α]D−5.8°(C=4.1、 25.0℃、 MeOH)1
HNMR(200M, CDCl3)δ:0.07 (3H,S); 0.08 (3H,
s); 0.85 (9H,s); 2.60(4H,m); 3.68 (3H,s); 4.55 (1
H,m)(2) Synthesis of (I-1) 8.41 g of the obtained (+) DHAA salt 2 was suspended in 100 ml of ether, and 4N-HCl-ethyl acetate solution 1 was added thereto.
Add 0 ml and stir. Further, 100 ml of pentane was added and stirred, the precipitate was filtered off, and the filtrate was concentrated under reduced pressure. The residue is dissolved in toluene and subjected to silica gel column chromatography (toluene / ethyl acetate = 2/1) to obtain 4.10 g of the target compound (I-1) as an oily substance having an optical purity of 96% ee or more. [Α] D −5.8 ° (C = 4.1, 25.0 ° C., MeOH) 1 HNMR (200M, CDCl 3 ) δ: 0.07 (3H, S); 0.08 (3H,
s); 0.85 (9H, s); 2.60 (4H, m); 3.68 (3H, s); 4.55 (1
H, m)
【0012】更に、光学純度は得られた化合物(I−
1)をR(+)1−フェネチルアミン−DCC−1−ヒ
ドロキシベンズトリアゾ−ルを用いて反応を行ない、H
eathcock(J.Org.Chem.,49,3657(1984))の方
法に準じてNMRより確認した。1
HNMR(200M, CDCl3)δ:0.07 (3H,s); 0.11 (3H,
s); 0.86 (9H,s); 1.47 (3H,d,J=7Hz); 2.35〜2.60 (4
H,m); 3.65 (3H,s); 4.50 (1H,m); 5.12 (1H,m); 6.57
(1H,br,d,J=7Hz); 7.32 (5H,m)Further, the optical purity of the obtained compound (I-
1) is reacted with R (+) 1-phenethylamine-DCC-1-hydroxybenztriazol to give H
It was confirmed from NMR according to the method of ethcock (J. Org. Chem., 49 , 3657 (1984)). 1 HNMR (200M, CDCl 3 ) δ: 0.07 (3H, s); 0.11 (3H,
s); 0.86 (9H, s); 1.47 (3H, d, J = 7Hz); 2.35 ~ 2.60 (4
H, m); 3.65 (3H, s); 4.50 (1H, m); 5.12 (1H, m); 6.57
(1H, br, d, J = 7Hz); 7.32 (5H, m)
【0013】実施例2 S−(+)−3−tert−ブチルジメチルシリルオキシグル
タル酸モノメチルエス
テル (I−2) Example 2 S-(+)-3-tert-butyldimethylsilyloxyglucurone
Tal acid monomethyl Es ether (I-2)
【化6】
(1)S−(+)−3−tert−ブチルジメチルシリルオキ
シグルタル酸モノメチル エステルのS(-)−1−フェネ
チルアミン塩 3
化合物2を得た際の母液を乾固して、200mlのエ−テ
ルに溶解する。撹拌下で4N−HCl−酢酸エチル溶液1
0mlを加えて、析出物を濾去し、濾液を濃縮してシリカ
ゲルカラムクロマトグラフィ−(トルエン/酢酸エチル
=2/1)に付し、溶出物を減圧下で濃縮する。残分を
20mlのペンタンにて溶解して−20℃下で二晩静置す
る。析出した結晶を濾去し、濾液中の溶媒を留去して光
学純度93%eeの油状物として粗(1−2)3.80
gを得る。この化合物1.00g(3.62mmol)、S-
(-)-1−フェネチルアミン440μl(3.50mmol)
を3mlのエ−テルに溶解し、更にペンタンを6ml加えて
1時間室温下で静置する。析出する結晶を濾取して化合
物31.27gを得る(融点:104〜105℃)。
[α]D +11.2°(C=1.00, 24.0℃, MeOH)
元素分析値(%)C20H35NO5Siとして
計算値:C,60.42; H,8.87; N,3.52
実験値:C,60.34; H,8.85; N,3.611
HNMR(200M,CDCl3)δ:0.04 (3H,s); 0.05 (3H,
s); 0.84 (9H,s); 1.50 (3H,d,J=6Hz); 2.30〜2.60 (4
H,m); 3.65 (3H,s); 4.11 (1H,q.J=6Hz); 7.25〜7.40
(5H,m)[Chemical 6] (1) S-(+)-3-tert-butyldimethylsilyloxy
Siglutaric acid monomethyl ester S (-)-1-phene
The mother liquor from which the tilamine salt 3 compound 2 was obtained is dried and dissolved in 200 ml of ether. 4N-HCl-ethyl acetate solution 1 under stirring
0 ml was added, the precipitate was filtered off, the filtrate was concentrated and subjected to silica gel column chromatography (toluene / ethyl acetate = 2/1), and the eluate was concentrated under reduced pressure. The residue is dissolved in 20 ml of pentane and left standing at -20 ° C for two nights. The precipitated crystals were filtered off and the solvent in the filtrate was distilled off to give crude (1-2) 3.80 as an oily substance having an optical purity of 93% ee.
get g. This compound 1.00 g (3.62 mmol), S-
(-)-1-Phenethylamine 440 μl (3.50 mmol)
Was dissolved in 3 ml of ether, 6 ml of pentane was added, and the mixture was allowed to stand at room temperature for 1 hour. The precipitated crystals are collected by filtration to obtain 1.27 g of compound 3 (melting point: 104-105 ° C). [Α] D + 11.2 ° (C = 1.00, 24.0 ° C, MeOH) Elemental analysis value (%) Calculated as C 20 H 35 NO 5 Si: C, 60.42; H, 8.87; N, 3.52 Experimental value: C , 60.34; H, 8.85; N, 3.61 1 HNMR (200M, CDCl 3 ) δ: 0.04 (3H, s); 0.05 (3H,
s); 0.84 (9H, s); 1.50 (3H, d, J = 6Hz); 2.30 to 2.60 (4
H, m); 3.65 (3H, s); 4.11 (1H, qJ = 6Hz); 7.25 ~ 7.40
(5H, m)
【0014】(2)化合物(I−2)の合成
化合物31.27gを50mlのエ−テル中に懸濁し、そ
こへ4N-HCl−酢酸エチル溶液2mlを加えて、室温で2
0分間撹拌する。不溶物を濾去し、濾液を減圧下濃縮し
て残分をペンタンにて溶解した後シリカゲル(トルエン
/酢酸エチル=2/1)にて精製して溶出液の溶媒を留
去して光学純度98%eeの目的化合物(I−2)86
1mgを得る。
[α]D +5.8°(C=4.1, 25.0℃, MeOH)1
HNMR(200M, CDCl3)δ:0.07 (3H,s); 0.08 (3H,
s); 0.85 (9H,s); 2.60 (4H,m); 3.68 (3H,s); 4.55 (1
H,m)
光学純度は同様にして、R(+)1−フェネチルアミン−
DCC−1−ヒドロクシベンズトリアゾ−ルと反応を行
ない、アミド誘導体としてHeathcockの方法に
て確認した。1
HNMR(200M, CDCl3)δ:0.03 (3H,
s); 0.07 (3H,s); 0.79 (9
H,s); 1.50 (3H,d,J=7Hz);
2.35−2.62 (4H,m); 3.69 (3
H,s); 4.50 (1H,m); 5.11
(1H,m);6.56 (1H,brd,J=7H
z); 7.32 (5H, m) (2) Synthesis of compound (I-2) 1.27 g of compound 3 was suspended in 50 ml of ether, 2 ml of 4N-HCl-ethyl acetate solution was added thereto, and the mixture was stirred at room temperature for 2 hours.
Stir for 0 minutes. The insoluble material was removed by filtration, the filtrate was concentrated under reduced pressure, the residue was dissolved in pentane, and the residue was purified by silica gel (toluene / ethyl acetate = 2/1). Target compound (I-2) 86 with 98% ee
I get 1 mg. [Α] D + 5.8 ° (C = 4.1, 25.0 ° C., MeOH) 1 HNMR (200M, CDCl 3 ) δ: 0.07 (3H, s); 0.08 (3H,
s); 0.85 (9H, s); 2.60 (4H, m); 3.68 (3H, s); 4.55 (1
H, m) optical purity is the same as R (+) 1-phenethylamine-
The reaction was carried out with DCC-1-hydroxicbenztriazole and confirmed as an amide derivative by the method of Heatcock. 1 HNMR (200M, CDCl 3 ) δ: 0.03 (3H,
s); 0.07 (3H, s); 0.79 (9
H, s); 1.50 (3H, d, J = 7Hz);
2.35-2.62 (4H, m); 3.69 (3
H, s); 4.50 (1H, m); 5.11
(1H, m); 6.56 (1H, brd, J = 7H
z); 7.32 (5H, m)
Claims (4)
いてもよい低級アルキル、*は不斉炭素原子をそれぞれ
表わす。)で示されるグルタル酸エステルのラセミ混合
溶液に(+)−デヒドロアビエチルアミンを作用させて、
R(-)グルタル酸エステルの(+)−デヒドロアビエチルア
ミン塩を生成させることを特徴とする光学活性なグルタ
ル酸エステルの回収方法。1. General formula (I): (Wherein R 1 represents a hydroxy protecting group, R 2 represents a lower alkyl which may have a substituent, and * represents an asymmetric carbon atom, respectively) to a racemic mixed solution of the glutaric acid ester (+ ) -Dehydroabietylamine,
A method for recovering an optically active glutaric acid ester, which comprises producing a (+)-dehydroabiethylamine salt of an R (-) glutaric acid ester.
請求項1記載のR(-)グルタル酸エステルの回収方法。2. The method for recovering R (−) glutaric acid ester according to claim 1, wherein the salt produced is decomposed.
ル酸エステルのアミン塩を形成し、更に塩分解すること
を特徴とする請求項1記載のS(+)グルタル酸エステル
の回収方法。3. The recovery of S (+) glutaric acid ester according to claim 1, wherein the mother liquor is reacted with an amine to form an amine salt of S (+) glutaric acid ester, and the salt is further decomposed. Method.
記載の方法。4. The amine is phenethylamine.
The method described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21453491A JP3272377B2 (en) | 1991-07-30 | 1991-07-30 | Optical resolution of optically active glutaric acid ester derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21453491A JP3272377B2 (en) | 1991-07-30 | 1991-07-30 | Optical resolution of optically active glutaric acid ester derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0532680A true JPH0532680A (en) | 1993-02-09 |
JP3272377B2 JP3272377B2 (en) | 2002-04-08 |
Family
ID=16657327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21453491A Expired - Lifetime JP3272377B2 (en) | 1991-07-30 | 1991-07-30 | Optical resolution of optically active glutaric acid ester derivatives |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3272377B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008130678A2 (en) * | 2007-04-18 | 2008-10-30 | Teva Pharmaceutical Industries Ltd. | Rosuvastatin intermediates and process for the preparation of rosuvastatin |
-
1991
- 1991-07-30 JP JP21453491A patent/JP3272377B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008130678A2 (en) * | 2007-04-18 | 2008-10-30 | Teva Pharmaceutical Industries Ltd. | Rosuvastatin intermediates and process for the preparation of rosuvastatin |
WO2008130678A3 (en) * | 2007-04-18 | 2008-12-11 | Teva Pharma | Rosuvastatin intermediates and process for the preparation of rosuvastatin |
EP2062903A1 (en) * | 2007-04-18 | 2009-05-27 | Teva Pharmaceutical Industries Ltd. | Statin intermediates and process for the preparation of statins |
JP2009538831A (en) * | 2007-04-18 | 2009-11-12 | テバ ファーマシューティカル インダストリーズ リミティド | Preparation method of rosuvastatin intermediate and rosuvastatin. |
Also Published As
Publication number | Publication date |
---|---|
JP3272377B2 (en) | 2002-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960003810B1 (en) | Process for producing optically active benzene-sulfonamide derivatives | |
KR0144684B1 (en) | Mono esters of dicarboxylic acids and their prepartion and use | |
ES2930284T3 (en) | Method for preparing a phenylalanine compound | |
JP3272377B2 (en) | Optical resolution of optically active glutaric acid ester derivatives | |
KR950005425B1 (en) | Process for enzymatic separation of optical isomers of 2-aminobutanol | |
GB2036744A (en) | Eburnane derivatives | |
JP2588969B2 (en) | Method for producing phenoxyethylaminopyrimidine derivative | |
CA1297878C (en) | Process for the obtention of the ethyl ester of the apovincaminic acid | |
JP2531708B2 (en) | Method for separating and purifying 3- (3,5-ditertiary butyl-4-hydroxyphenyl) propionic acid ester | |
US5149857A (en) | Process for production of sulfonium compounds | |
JPH083143A (en) | Production of 6-aralkyl substituted pyrimidine derivative | |
EP2448916B1 (en) | Production of trans-4-aminocyclopent-2-ene-1-carboxylic acid derivatives | |
JP3345637B2 (en) | Method for producing hydroxy compound and catalyst for producing the same | |
SE8205563D0 (en) | PROCESS FOR THE PREPARATION OF VINCAMINIC ACID ESTERS | |
US5525722A (en) | Process for producing biocozamycin benzoate | |
JP2940395B2 (en) | Preparation of oxyglutarate derivatives | |
EP0345457B1 (en) | Antinflammatory agent for the therapy of prostatic hypertrophy, a process for the preparation thereof and pharmaceutical compositions containing it | |
RU2083560C1 (en) | Process for preparing individual stereoisomers of 4- substituted glutamic acid thioderivatives | |
JPH01100147A (en) | Optically active malonic acid ester derivative | |
JPH0812658A (en) | Production of sydnones | |
JPS6317869A (en) | Production of 2-lower alkyl-4-amino-5-formylpyrimidine | |
JPH10195075A (en) | Production of z-valacyclovir | |
JP2002069069A (en) | Derivative of 3,5,6-trihydroxyhexanoic acid ammonium salt and method of preparing the same | |
JPS6321661B2 (en) | ||
JPS5940812B2 (en) | Method for producing α-keto acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080125 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090125 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090125 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100125 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100125 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120125 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120125 Year of fee payment: 10 |